AmerisourceBergen changes operating model, leadership team

VALLEY FORGE, Pa. — AmerisourceBergen on Monday shared its new organizational structure, which it said was aimed at aligning the company with its customers’ needs while accelerating growth and supporting its corporate strategy. As a result, its customer-facing offerings will be divided into two divisions — pharmaceutical distribution and strategic global sourcing and global commercialization services and animal health.

Group president Bob Mauch will lead the pharmaceutical distribution and strategic global sourcing group, which will include the company’s services to retail chain and independent pharmacies, health systems, physician practices and alternate care sites, as well as its sourcing, repackaging and specialty pharmacy capabilities. Within this group, Peyton Howell will assume a new role as president of health systems, physician practices and strategic health solutions.

Group president James Cleary, Jr., will head the company’s global commercialization services and pet health division, which will include AmerisourceBergen’s solutions for product commercialization and patient access, as well as international development and animal health.

“AmerisourceBergen has assembled and built best-in-class capabilities to support every stage of pharmaceutical care, with the goal of ensuring access to medicines that create healthier futures for patients,” AmerisourceBergen president, chairman and CEO Steve Collis said. “This strategy has served as the engine of AmerisourceBergen’s success and we are now evolving our organization to capitalize on our unique portfolio of services. Our vision is to accelerate AmerisourceBergen’s corporate growth by further aligning our operating model to the dynamic customer needs in the health and pharmaceutical industry.”

The company also has named a new management committee to facilitate faster decision-making. The group comprises:

• 
  Collis


• 
  Chief legal and business officer John Chou, who will now oversee legal and regulatory affairs alongside strategy, innovation and business development and information technology;


• 
  Chief communications and administration officer Gina Clark, who will now oversee marketing, communication, corporate citizenship and sustainability alongside human resources and government affairs


• 
  Cleary


• 
  CFO Tim Guttman; and


• 
  Mauch

Additionally, AmerisourceBergen EVP and president of AmerisourceBergen Specialty Group will be departing the company for new opportunities, the company said, noting that he would stay on board for the next few months as he transitions from his role.

“We are better positioned to meet the needs of the marketplace because of James’ leadership and I’m truly grateful for his guidance and partnership over the past decade,” Collis said. “We will carry that industry leadership into our new management committee structure. This group will be singularly focused on aligning every aspect of AmerisourceBergen to our purpose, corporate strategy and continued growth. We believe this next evolution of AmerisourceBergen will enable the Company to be more nimble and effective, actively supporting our customers as they grow and unlock the full value of their businesses.”

For financial reporting purposes, AmerisourceBergen operations will continue to be divided into the Pharmaceutical Distribution Services reportable segment and other, the company said.